Tokyo (JCN) - Nihon Medi-Physics announced on September 28 that it has begun supplying FDG Scan Injection (fludeoxyglucose F-18), its proprietary radiopharmaceutical for positron emission tomography (PET) imaging, to medical institutions on September 16.
